REYL & Cie S.A.’s AbbVie ABBV Stock Holding History

REYL & Cie S.A.’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.2K	Buy	+189	New	+$40.7K	0.05%	119

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

REYL & Cie S.A.'s ABBV Position: Q2 2026 in Review

REYL & Cie S.A. opened a new position in AbbVie (ABBV) in Q2 2026: 189 shares worth $41.2K. The stake represents 0.05% of the portfolio and ranks #119 among its holdings.

4,233 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

REYL & Cie S.A. held 189 shares of AbbVie worth $41.2K as of Q2 2026.
AbbVie was a new REYL & Cie S.A. position in Q2 2026.
AbbVie made up 0.05% of REYL & Cie S.A.'s portfolio in Q2 2026, its #119 holding.
4,233 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on REYL & Cie S.A.'s 13F filing for Q2 2026, filed 2 Oct 2026.